Company BB Biotech AG Xetra

Equities

BBZA

CH0038389992

Biotechnology & Medical Research

Market Closed - Xetra 11:35:50 2024-07-12 am EDT 5-day change 1st Jan Change
43.3 EUR -0.23% Intraday chart for BB Biotech AG +4.97% -4.84%

Business Summary

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.

Number of employees: 10

Sales per Business

CHF in Million2022Weight2023Weight Delta
Biotechnology
100.0 %
1 100.0 % 1 100.0 % -57.97%

Sales per region

CHF in Million2022Weight2023Weight Delta
Switzerland
100.0 %
1 100.0 % 1 100.0 % -57.97%

Managers

Managers TitleAgeSince
Chief Investment Officer 54 03-12-31
- -
- -
Corporate Officer/Principal - 03-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 03-12-31
Director/Board Member 63 19-12-31
Chairman 63 19-03-20
Director/Board Member 66 22-03-16
Director/Board Member 60 22-03-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 55,400,000 53,870,953 ( 97.24 %) 554,000 ( 1.000 %) 97.24 %

Shareholders

NameEquities%Valuation
957,884 1.729 % 43 M €
554,000 1.000 % 25 M €
Union Bancaire Privée, UBP SA
0.3256 %
180,372 0.3256 % 8 M €
Basler Kantonalbank (Investment Management)
0.1938 %
107,350 0.1938 % 5 M €
DWS CH AG
0.1060 %
58,713 0.1060 % 3 M €
Valiant Bank AG
0.1057 %
58,540 0.1057 % 3 M €
Joh. Berenberg, Gossler & Co. KG (Investment Management)
0.0980 %
54,300 0.0980 % 2 M €
West Yorkshire Pension Fund
0.0902 %
49,950 0.0902 % 2 M €
Debeka Asset Management GmbH
0.0857 %
47,500 0.0857 % 2 M €
BIL Manage Invest SA
0.0794 %
44,000 0.0794 % 2 M €

Holdings

NameEquities%Valuation
8,590,000 5.88% 409,399,400 $
3,505,000 5.82% 38,064,300 $
554,000 1.00% 24,722,233 $
4,682,290 4.44% 22,943,221 $
4,494,458 3.67% 22,427,345 $
1,279,820 19.44% 1,471,793 $

Company contact information

BB Biotech AG

Schwertstrasse 6

8200, Schaffhausen

+41 44 2676700

http://www.bbbiotech.com
address BB Biotech AG(BBZA)

Group companies

NameCategory and Sector
Biotech Invest NV
Biotech Focus NV
Financial Conglomerates
Miscellaneous

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
42.4 CHF
Average target price
47.7 CHF
Spread / Average Target
+12.50%
Consensus

Annual profits - Rate of surprise